Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 9222375)

Published in J Neurovirol on December 01, 1995

Authors

K Yokomori1, M Asanaka, S A Stohlman, S Makino, R A Shubin, W Gilmore, L P Weiner, F I Wang, M M Lai

Author Affiliations

1: Department of Microbiology, University of Southern California, School of Medicine, Los Angeles 90033-1054, USA.

Articles citing this

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18

Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol (2011) 1.60

Sialic acids as receptor determinants for coronaviruses. Glycoconj J (2006) 1.39

Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol (1999) 1.38

Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J Virol (2005) 1.19

Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity. J Virol (2011) 1.04

Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol (2010) 0.99

Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J Virol (2005) 0.95

Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J Virol (2005) 0.94

Murine coronavirus neuropathogenesis: determinants of virulence. J Neurovirol (2010) 0.85

The spike protein of murine coronavirus regulates viral genome transport from the cell surface to the endoplasmic reticulum during infection. J Virol (2009) 0.80

Coronaviruses. J Neurovirol (1995) 0.76

Articles by these authors

Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21

Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (1980) 5.03

A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (1993) 4.59

DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54

Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52

Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49

Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun (1986) 4.33

RNA of mouse hepatitis virus. J Virol (1978) 4.27

The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07

Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00

Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56

Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51

Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol (1973) 3.50

Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46

Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40

Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett (1991) 3.35

virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31

Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24

Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11

Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09

The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09

Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06

High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91

Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86

A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri. Mol Microbiol (1989) 2.81

The murine autoimmune diabetes model: NOD and related strains. Adv Immunol (1992) 2.80

Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80

Circadian waves of expression of the APRR1/TOC1 family of pseudo-response regulators in Arabidopsis thaliana: insight into the plant circadian clock. Plant Cell Physiol (2000) 2.61

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group. Neurology (1998) 2.52

Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46

Molecular characterization of proteins in detergent solutions. Biochemistry (1974) 2.36

The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36

Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33

Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis (1992) 2.30

Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30

Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28

Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28

DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun (1986) 2.22

Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22

Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21

Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19

The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17

Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17

A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16

Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16

Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13

Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11

Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10

Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07

Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia (1984) 2.07

Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07

Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri. Infect Immun (1986) 2.05

Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01

IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00

Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00

Host cell nuclear function and murine hepatitis virus replication. J Gen Virol (1981) 2.00

The olivopontocerebellar atrophies: a review. Medicine (Baltimore) (1970) 1.98

Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol Microbiol (1993) 1.96

High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95

Double termination of the alimentary tract in females: a report of 12 cases and a literature review. J Pediatr Surg (1984) 1.90

Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90

An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90

Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89

Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89

Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology (1993) 1.89

Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut (2005) 1.88

Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87